Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standex International Corporation (NYSE: SXI) SEC filings page provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Standex’s financial performance, governance practices, executive compensation, and shareholder matters.
Standex submits a variety of forms, including Form 8-K current reports and its DEF 14A definitive proxy statement. Recent Form 8-K filings have covered topics such as the announcement of quarterly earnings, the results of the Annual Meeting of Shareholders, and changes in executive roles. Through these reports, investors can review information on segment performance across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, as well as commentary on revenue, margins, and capital allocation.
The company’s definitive proxy statement describes board leadership structure, board committees, strategy and risk oversight, ESG strategy and risks, director compensation, director independence, and stock ownership. It also details the items presented to shareholders for voting, including director elections, advisory votes on executive compensation, and ratification of the independent auditors.
On this page, filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy documents, helping users quickly identify topics such as shareholder vote outcomes, executive compensation disclosures, and significant corporate events reported on Form 8-K. Investors can use these summaries alongside the full-text filings to better understand Standex’s regulatory reporting and governance framework.
Standex International (SXI) director reported an equity grant. On 10/21/2025, the reporting person acquired 639 shares of common stock as a grant of restricted stock under the Company’s 2018 Omnibus Incentive Plan, vesting three years after the grant date. The filing lists the transaction price as $0, consistent with a stock grant. Following the grant, the filer beneficially owned 3,575 shares directly and 13,751 shares indirectly as trustee of a trust.
Standex International (SXI) reported a director’s Form 4 showing stock acquired through the vesting of phantom stock units tied to the director’s retirement. On 10/21/2025, the director acquired common stock via transaction code M in three lots: 663 shares at $106.10, 581 shares at $120.86, and 599 shares at $117.36. Following these transactions, the director beneficially owned 11,389.254 shares directly. The related phantom stock unit awards were converted, leaving 0 derivative securities beneficially owned after the reported transactions.
Standex International (SXI) reported insider transactions by an individual who is both a Director and the President/CEO/Chairman. On 10/15/2025, the insider reported two sales totaling 18,000 shares at $235 per share, executed pursuant to a Rule 10b5-1 trading plan dated November 22, 2024. The transactions were reported as indirect holdings in the capacity of Trustee of a Trust.
SXI: A Form 144 notice discloses a proposed sale of 18,000 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $4,230,000. The approximate sale date is October 15, 2025. The filing lists 12,068,262 shares outstanding.
The securities to be sold were acquired via RSU vests from the issuer on 09/06/2023 (13,000 shares) and 09/06/2022 (5,000 shares). Recent activity over the past three months includes sales by related trusts: 5,000 shares for $1,000,000 on 08/13/2025, and 11,000 shares for $2,200,000 on 08/13/2025, plus 11,000 shares for $2,365,000 on 09/18/2025. This notice outlines an intended sale under Rule 144 by the holder, separate from the company’s capital-raising activities.
Standex International Corp reporting person David A. Dunbar, who is listed as President/CEO/Chairman and Director, sold shares under an existing trading plan. The filing shows a sale of 11,000 shares of common stock on 09/18/2025 at a price of $215 per share, executed pursuant to a 10b5-1 plan dated November 22, 2024. After the reported transaction, the reporting person is shown as beneficially owning 121,973 shares indirectly. The form also references 1,429.9759 shares in connection with a trustee relationship. The form is signed by Alan J. Glass on 09/19/2025.
Standex International Corp. (SXI) notice reports a proposed sale of 11,000 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $2,365,000 and approximately 12,068,262 shares outstanding. The shares were acquired on 09/06/2023 by vesting of restricted stock units (RSU vest) from the issuer. The filing also discloses related sales within the past three months: a sale of 5,000 shares for $1,000,000 and a sale of 11,000 shares for $2,200,000, both dated 08/13/2025. The filer certifies no undisclosed material adverse information and references the Rule 10b5-1 trading plan representation.
Standex International Corporation is holding its 2025 Annual Meeting of Shareholders on October 21, 2025 at its Salem, New Hampshire headquarters. Shareholders of record as of August 26, 2025 can vote in person, by Internet, phone or mail on three proposals.
These proposals are the election of two Class III directors (Thomas E. Chorman and Andy L. Nemeth) for terms expiring in 2028, an advisory “Say on Pay” vote on executive compensation, and the ratification of Deloitte & Touche LLP as independent auditors for fiscal 2026.
The proxy highlights extensive governance practices, including a majority-independent board, fully independent key committees, a lead independent director, mandatory board retirement age, stock ownership guidelines, anti-hedging and anti-pledging policies, and ESG and cybersecurity oversight. Deloitte audit and related fees totaled $4,153,000 in FY 2025, and CEO David Dunbar’s total compensation was $5,117,281, with a large portion in equity and incentive pay tied to performance.
David A. Dunbar, identified as a director and as an officer with the title President/CEO/Chairman of Standex International Corp (SXI), reported transactions dated 09/03/2025 on a Form 4. The filing shows two non-derivative entries for Common Stock with transaction code J(1) and quantity 17,397 shares on each reported line. One line shows those shares as Disposed (D) at $0 with a following beneficial ownership figure shown as 1,429.9759 D in the table. The second line shows the same quantity as Acquired (A) at $0 with a following beneficial ownership figure shown as 132,973 I and the notation Trustee of Trust. The explanatory note states these transactions reflect shares gifted by the reporting person to a revocable trust for which he is Trustee.
Standex International (SXI) Form 4: Annemarie Bell, VP and Chief HR Officer, reported a transaction on 09/03/2025 disposing of 1,184 shares of common stock at $202.12 per share. After the sale she beneficially owns 7,422 shares. The filing indicates the form was signed on 09/04/2025.
Andy L. Nemeth, a director of Standex International Corporation (SXI), purchased 1,500 shares of the issuer's common stock on 08/29/2025 at a reported price of $205 per share. After the transaction he beneficially owned 6,000 shares. The Form 4 indicates the filing was executed on behalf of the reporting person and signed on 09/03/2025. The report contains no derivative transactions and lists the ownership form as direct. No additional explanation or context for the purchase is provided in the filing.